Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Yoshimi Kaise"'
Autor:
Jun Arai, Naoya Kato, Yoshimi Kaise, Chisato Saeki, Kazuhiko Koike, Keiko Takano, Ryo Nakagawa, Mikio Zeniya, Ryosuke Muroyama, Masayuki Saruta, Yasuo Matsubara, Tsunekazu Oikawa, Masanori Nakano, Yoshihiro Hirata
Publikováno v:
Hepatology Research. 49:653-662
Aim Primary biliary cholangitis (PBC) is an autoimmune liver disease with unknown pathogenesis. In PBC, activation of T-cell receptor (TCR) signaling is associated with inflammatory cytokine production through N-Ras upregulation. Although the CD4+ T
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d2bba7563879330bc62d2a8d2289596e
https://doi.org/10.1111/hepr.13318
https://doi.org/10.1111/hepr.13318
Autor:
Ryosuke Muroyama, Hitoshi Yoshida, Naoya Kato, Yoshimi Kaise, Yasuo Matsubara, Kaku Goto, Sayuri Morimoto, Lay Ahyoung Lim, Ryo Nakagawa, Anthony Stephanou, Jun Arai, Sayaka Ito, Yasushi Tanoue
Publikováno v:
Journal of Gastroenterology and Hepatology. 33:1075-1081
Background and Aim The multi-kinase inhibitor regorafenib (REG) was recently demonstrated to be effective in patients with sorafenib (SOR)-resistant hepatocellular carcinoma (HCC). Interestingly, SOR is known to enhance the accumulation of membrane-b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::12ec8d72f64cb14e3a6caca74770ecaa
https://doi.org/10.1111/jgh.14029
https://doi.org/10.1111/jgh.14029
Autor:
Kazuhiko Koike, Ryosuke Muroyama, Chisato Saeki, Naoya Kato, Masayuki Saruta, Keiko Takano, Yoshimi Kaise, R. Nakagawa, Sayaka Ito, Masanori Nakano, Kaku Goto, Mikio Zeniya, Yasuo Matsubara
Publikováno v:
Journal of Hepatology. 66:1223-1230
Background & Aims Primary biliary cholangitis (PBC) is an autoimmune liver disease of unknown pathogenesis. Consequently, therapeutic targets for PBC have yet to be identified. CD4 + T cells play a pivotal role in immunological dysfunction observed i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::192289c6da5ca015932d5f6e15f2e310
https://doi.org/10.1016/j.jhep.2017.02.002
https://doi.org/10.1016/j.jhep.2017.02.002
Autor:
Ryo, Nakagawa, Ryosuke, Muroyama, Chisato, Saeki, Tsunekazu, Oikawa, Yoshimi, Kaise, Kazuhiko, Koike, Jun, Arai, Masanori, Nakano, Yasuo, Matsubara, Keiko, Takano, Yoshihiro, Hirata, Masayuki, Saruta, Mikio, Zeniya, Naoya, Kato
Publikováno v:
Hepatology research : the official journal of the Japan Society of Hepatology. 49(6)
Primary biliary cholangitis (PBC) is an autoimmune liver disease with unknown pathogenesis. In PBC, activation of T-cell receptor (TCR) signaling is associated with inflammatory cytokine production through N-Ras upregulation. Although the CD4Four PBC
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::fc5fd6f80572ee85769893a0b13c8a8d
https://pubmed.ncbi.nlm.nih.gov/30690835
https://pubmed.ncbi.nlm.nih.gov/30690835
Autor:
Yoshimi Kaise, Yasuo Matsubara, Hitoshi Yoshida, Ryosuke Muroyama, Yasushi Tanoue, Jun Arai, Ryo Nakagawa, Sayaka Ito, Naoya Kato, Lay Ahyoung Lim, Kaku Goto
Publikováno v:
International journal of cancer. 143(10)
In our previous study on hepatocellular carcinoma (HCC) susceptibility genes in chronic hepatitis patients, we identified the MHC class I polypeptide-related sequence A (MICA). Natural killer cells eliminate various cancer cells, including HCC, by su
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e1e0369ea13b0a364718ae735524944d
https://pubmed.ncbi.nlm.nih.gov/29873070
https://pubmed.ncbi.nlm.nih.gov/29873070
Autor:
Jun, Arai, Kaku, Goto, Anthony, Stephanou, Yasushi, Tanoue, Sayaka, Ito, Ryosuke, Muroyama, Yasuo, Matsubara, Ryo, Nakagawa, Sayuri, Morimoto, Yoshimi, Kaise, Lay Ahyoung, Lim, Hitoshi, Yoshida, Naoya, Kato
Publikováno v:
Journal of gastroenterology and hepatology. 33(5)
The multi-kinase inhibitor regorafenib (REG) was recently demonstrated to be effective in patients with sorafenib (SOR)-resistant hepatocellular carcinoma (HCC). Interestingly, SOR is known to enhance the accumulation of membrane-bound MHC class I po
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::69c133194f65e4140374aedcbd476516
https://pubmed.ncbi.nlm.nih.gov/29055152
https://pubmed.ncbi.nlm.nih.gov/29055152
Autor:
Ryo, Nakagawa, Ryosuke, Muroyama, Chisato, Saeki, Kaku, Goto, Yoshimi, Kaise, Kazuhiko, Koike, Masanori, Nakano, Yasuo, Matsubara, Keiko, Takano, Sayaka, Ito, Masayuki, Saruta, Naoya, Kato, Mikio, Zeniya
Publikováno v:
Journal of hepatology. 66(6)
Primary biliary cholangitis (PBC) is an autoimmune liver disease of unknown pathogenesis. Consequently, therapeutic targets for PBC have yet to be identified. CD4Integral miRNA and mRNA analysis of 14 PBC patients and ten healthy controls was carried
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::8b5c65f212dc83f8a5d844b2b35c92c4
https://pubmed.ncbi.nlm.nih.gov/28192189
https://pubmed.ncbi.nlm.nih.gov/28192189